Use of recombinant hirudin as antithrombotic treatment in patients with heparin‐induced thrombocytopenia

American Journal of Hematology

Volumn 50, Issue 1, 1995, Pages 20-25

  Schiele, F ^a   Vuillemenot, A ^a   Kramarz, P ^a   Kieffer, Y ^b   Anguenot, T ^a   Bernard, Y ^a   Bassand, J P ^a  

^a HÔPITAL SAINT JACQUES   (France)

^b Etablissement de Transfus Sanguine   (France)

Author keywords

heparin induced thrombocytopenia; oral coagulation; recombinant hirudin

Indexed keywords

ACENOCOUMAROL; ENOXAPARIN; HEPARIN; LEPIRUDIN; NADROPARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS;

AGED; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HIRUDIN THERAPY; HUMAN; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGE; RECOMBINANT PROTEINS; THROMBOCYTOPENIA;

EID: 0029161648     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.2830500105     Document Type: Article

References (28)

1. Antibodies from patients with heparin induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells
2. Heparin associated thrombocytopenia: The effects of various intravenous IgG preparations on antibody mediated platelet activation. A possible new indication for high dose i.v.
3. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia
4. Heparin‐induced thrombocytopenia
5. Heparin‐induced thrombocytopenia: Studies with a new low molecular weight heparinoid, Org 10172
6. Rapid anticoagulation using ancrod for heparin‐induced thrombocytopenia
7. Heparin‐induced thrombocytopenia and thrombosis: Reversal with streptokinase. A case report and review of the literature
8. Plasmapheresis. A therapeutic option in the management of heparin‐associated thrombocytopenia with thrombosis
9. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis
10. Comparative effects of heparin and hirudin on fibrinolytic and thrombotic activities during tissue‐type plasminogen activator therapy
11. Hirudin therapy for heparin‐associated thrombocytopenia and deep venous thrombosis
12. Heparin induced thrombocytopenia
13. Treatment of severe venous thrombo‐embolism with intravenous hirudin (HBW 023). an open pilot study
14. HIT (Hirudin for the improvement of thrombolysis): Results of a dose escalation study
15. Heparin induced thrombocytopenia: Effect of heparin‐dependent antibody on platelets
16. Carotid endarterectomy in patients with heparin‐induced‐platelet activation: Comparative efficacy of aspirin and iloprost (ZK 36374)
17. Heparin associated thrombocytopenia: Management of patients for open heart surgery. Case reports describing the use of iloprost
18. Heparin induced platelet activation in sixteen surgical patients: Diagnosis and management
19. Plasmapheresis in the management of heparin‐associated thrombocytopenia with thrombosis
20. Heparin‐associated‐thrombocytopenia: Alternative managements
21. Heparin‐induced thrombocytopenia and thrombosis: Optimal therapy with Ancrod
22. Streptokinase therapy of pulmonary emboli with heparin‐associated thrombocytopenia
23. Traitement par thrombolyse locale d'une thrombose arterielle massive par thrombopenie induite par l'héparine
24. Les thrombopénies graves à l'héparine: Intéret de l'utilisation de l'héparine à bas poids moléculaire. A propos de 6 observations
25. Persistent thrombocytopenia despite therapy with low molecular weight heparin
26. Heparin‐associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing cross reaction to low molecular weight heparins
27. Treatment of heparin‐induced thrombocytopenia by a new heparinoid
28. Treatment of heparin‐induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor